CD109 expression was also found to be more frequent in lung squamous cell carcinomas compared with other types of lung carcinoma including adenocarcinomas, large cell carcinomas and small cell carcinomas; however, no association between CD109 expression and the clinical stage of the disease was found [20]. This evidence concerns the gene CD109 and adenocarcinoma.